Subscribe to RSS
DOI: 10.1055/s-0037-1610722
Rhodium-Catalyzed Asymmetric Addition of Arylboronic Acids to Glyoxylates: Access to Optically Active Substituted Mandelic Acid Esters
The National Science & Technology Major Project (2018ZX09711002-006), National Natural Science Foundation of China (81521005, 21472205, 21325209)
Publication History
Received: 31 May 2019
Accepted after revision: 25 June 2019
Publication Date:
17 July 2019 (online)
◊ D.C. and J.G.L. contributed equally.Published as part of the Cluster Organosulfur and Organoselenium Compounds in Catalysis
Abstract
A rhodium-catalyzed enantioselective addition of glyoxylates to arylboronic acids promoted by a simple chiral sulfinamide-based olefin ligand under mild reaction conditions is described. The reaction provides access to a variety of optically active substituted mandelic acid esters in good yields with up to 83% ee. The catalytic system is also applicable to pyruvate addition. The synthetic utility of this method is highlighted by a formal synthesis of the antiplatelet drug clopidogrel.
#
Key words
asymmetric catalysis - rhodium catalysis - ligands - mandelic acid esters - glyoxylate - arylboronic acidsOptically active α-hydroxy acid structural motifs are ubiquitous in a large variety of biologically active compounds, and they are often used as important intermediates for pharmaceuticals.[1] Due to their great importance in synthetic and medicinal chemistry, considerable efforts have been devoted to the asymmetric synthesis of chiral mandelic acid derivatives in recent decades. Among these, the enzymatic[2] or nonenzymatic[3] asymmetric reduction of α-aryl keto esters has proven to be an efficient protocol. The asymmetric intramolecular Cannizzaro reaction[4] of α-keto aldehydes and the asymmetric resolution[5] of racemic α-hydroxy acids also afford chiral mandelic acids with medium to good enantioselectivities. In addition, the asymmetric addition of carbon nucleophiles to glyoxylates represents another efficient protocol. Excellent enantioselectivities can be achieved in some asymmetric Friedel–Crafts reactions[6] or in asymmetric additions with aryl(trimethoxy)silanes.[7] Nevertheless, nucleophilic substrates are limited to electron-rich aromatic compounds or appropriate organosilane reagents. In recent years, the use of organoboron reagents, which are widely available from commercial sources, as nucleophiles in transition-metal-catalyzed asymmetric additions has received a great deal of attention, with some significant successes. However, enantioselective addition of glyoxylate to organoboron reagents still remains a challenging task, and there have been only three reports of this in the literature.[8] Notably, Yamamoto et al. reported a ruthenium-catalyzed asymmetric addition of arylboronic acids to tert-butyl glyoxylate by using a RuCl2(PPh3)3/(R,R)-2,2′-[oxydi(methylene)]bis(N,N-dimethyldinaphtho[1,2-f:2′,1′-d][1,3,2]dioxaphosphepin-4-amine) [(R,R)-Me-BIPAM] catalyst for the synthesis of optically active substituted mandelic acid esters with good to high enantioselectivity.[8c]
Over the past few years, we have been involved in the design and synthesis of novel chiral olefin ligands for asymmetric catalysis. Interestingly, chiral sulfur-based olefins bearing simple molecular architectures showed highly promising performance in many rhodium-catalyzed asymmetric transformations[9] and they proved to be elegant ligands, particularly in enantioselective additions to carbonyl compounds[10] and imines.[11] In our previous work, we have been succeeded in the asymmetric addition of arylboronic acids to α-keto esters,[10a] [b] α-diketones,[10c,e] and nonactivated ketones.[10d] Encouraged by these successes, and to address the difficulties in enantiocontrol of glyoxylate addition, we surmised that this newly emerging class of chiral sulfur olefins might serve as effective ligands. Here, we describe our development of a new catalytic system of this type that permits the convenient preparation of optically active substituted mandelic acid esters with synthetically useful enantioselectivities under mild conditions.
We initially examined the rhodium-catalyzed 1,2-addition of ethyl glyoxylate to (4-methoxyphenyl)boronic acid (2a) by using our previously developed linear sulfur olefin ligand (SOL) L1 in a 0.1 M aq KOH–THF at 40 °C in the presence of 1.5 mol% chlorobis(cyclooctene)rhodium dimer {[Rh(COE)2Cl]2} (Scheme [1]). To our delight, we found that the reaction proceeded smoothly and gave the desired mandelic acid ester 3a in 72% yield with 70% ee. On the basis of this promising result, we investigated a number of chiral SOLs L2–5 bearing various substituent groups (R) on the double bond. However, screening of these ligands gave no better results. Interestingly, the structurally simplest chiral N-(sulfinyl)cinnamylamine L1 exhibited the best enantiocontrol (70% ee). When branched SOLs L6 and L7 were tested, a clear decrease in the enantioselectivity was observed. To improve the enantioselectivity, we tried elaborating the structure of linear ligand L1 by introducing an additional substituent on the allylic site adjacent to the sulfinyl amide nitrogen. By taking advantage of Grignard addition to the sulfinimine[12] of cinnamaldehyde, a series of chiral SOLs L8–14 with an additional carbon stereocenter were prepared. Gratifyingly, in all cases the (S,R s)-SOLs L8–12 produced an obvious increase in enantioselectivity. SOLs L11 and L12, bearing a tert-butyl or phenyl group, respectively, showed markedly improved enantioselectivities (80% ee) and catalytic activity (82% yield). Notably, unlike the Rh(I)-catalyzed asymmetric 1,4-addition reactions,[13] the carbon stereochemistry of ligand significantly affected the activity and enantioselectivity, leading to a much lower enantioselectivity and yield when (R,R s)-SOLs L13 and L14 were employed.


Next, the effect of the ester group in glyoxylate was investigated, following up on the results obtained with L12 (Table [1]). The reactions of benzyl (Bn), isopropyl ( i Pr), or tert-butyl ( t Bu) glyoxylate all proceeded smoothly in 0.1 M aq KOH–THF at 40 °C to give the corresponding products with nearly the same levels of enantioselectivity (~80% ee) (Table [1], entries 1–3). Solvent assessment using isopropyl glyoxylate as the substrate revealed that 1,4-dioxane gave a slightly higher yield and enantioselectivity (entries 4–6). Performing the reaction at room temperature did not give a better result (entry 7). Further exploration of additives such as KF and K3PO4 led to much lower yields (entries 8 and 9).
a Reaction conditions: 1 (0.25 mmol), 2a (0.5 mmol), [Rh(COE)2Cl]2 (1.5 mol%), L12 (3.3 mol%), 0.1 M KOH (0.1 mL, 0.01 mmol) in solvent (2 mL), 40 °C, <5 h.
b Isolated yield.
c Determined by chiral HPLC.
d At r.t.
e With 1.5 M KF at r.t.
f With 0.1 M K3PO4 at r.t.
Having determined the optimal conditions, we turned our attention to an investigation of the scope of the reaction (Table [2]). A broad range of arylboronic acids bearing various electron-donating or electron-withdrawing groups at various positions of the phenyl ring were treated with isopropyl glyoxylate. We were pleased to find that in most cases the addition reactions proceeded smoothly to give the corresponding products in good to high yields with moderate to good enantioselectivities (55–83% ee). It appeared that electron-withdrawing substituents on the phenyl ring have a detrimental effect on both the yield and enantioselectivity (Table [2], entries 4 and 8–10). The reaction was effective with sterically hindered arylboronic acids, albeit with decreased ee values (entries 10–12). It is notable that the reaction appeared to suffer from steric hinderance under rhodium catalysis in a previous study.[8b] The absolute configuration of the newly generated carbon stereocenter of product 3e was determined to be S by comparison of its optical rotation with reported data.[5a]
a Reaction conditions: glyoxylate 1 (0.2 mmol), arylboronic acid (0.4 mmol), 0.1 M KOH (0.1 mL, 0.01 mmol), [Rh(COE)2Cl]2 (1.5 mol%), L12 (3.3 mol%) in 1,4-dioxane (2 mL), stirring, 40 °C, 5–6 h.
b Isolated yield.
c Determined by chiral HPLC.
The stereochemistry of the sulfur olefin L12 was confirmed by X-ray analysis of a single crystal (Figure [1]).[14] A plausible transition-state model of the reaction stereocontrol is proposed (Figure [1]). Transmetalation of the arylboronic acid reagent leads to an arylrhodium species with a favorable conformation in which the aryl group is positioned trans to the olefin and the tert-butyl moiety is staggered. The phenyl substituent on the allylic chiral carbon has the same effect as the tert-butyl group of the sulfinyl moiety in blocking the rear side. The formyl moiety of the substrate coordinates to the rhodium in such a way that the ester is oriented away from the phenyl group attached to the double bond; thus, arylation of the glyoxylate ester takes place from the Re-face of the formyl group to give the S-product.


Enantioselective addition of similar ketone analogues would be also of great interest, as the resulting α-hydroxy acid derivatives would contain a much more challenging quaternary carbon stereocenter. We therefore conducted the reaction of ethyl pyruvate with (4-methoxyphenyl)boronic acid under our standard conditions. In the presence of L12, the desired addition product 4a was obtained in 54% yield with 53% ee (Scheme [2]). Interestingly, the best result was obtained by using the 2-biphenyl-substituted chiral SOL L16, giving 4a in 98% yield with 64% ee. The absolute configuration at the stereogenic center of 4a was determined to be S by comparison of its optical rotation with that of the known compound.[15]


To demonstrate the synthetic utility of our method, we explored the synthesis of clopidogrel, an antiplatelet drug developed by Bristol-Myers Squibb for the treatment of atherosclerotic vascular disease and cerebrovascular disease. By using the (R,S s)-SOL L12 as the ligand, the desired addition product (R)-3l was obtained with 70% ee. Transesterification of (R)-3l with methanol, followed by formation of the 4-nitrobenzenesulfonate of the alcohol, gave the key intermediate 5 in 68% yield with 69% ee (Scheme [3]). Notably, the optical purity of 5 could be readily improved to 96% ee after one recrystallization from petroleum ether–EtOAc. Asymmetric synthesis of clopidogrel could then be accomplished under the known conditions.[16]


In summary, we have developed a novel rhodium-catalyzed enantioselective addition of arylboronic acids to glyoxylate esters by employing simple chiral sulfinamide olefins as ligands. The reaction proceeds under mild conditions, affording a range of optically active substituted mandelic acid esters with up to 83% ee.[17] [18] The catalyst system is also applicable to pyruvate addition for the synthesis of chiral quaternary carbon-containing α-hydroxy esters. Furthermore, the application of this method to the asymmetric synthesis of antiplatelet drug clopidogrel is showcased.
#
Supporting Information
- Supporting information for this article is available online at https://doi-org.accesdistant.sorbonne-universite.fr/10.1055/s-0037-1610722.
- Supporting Information
-
References and Notes
- 1a Comprehensive Asymmetric Catalysis . Jacobsen EN, Pfaltz A, Yamamoto H. Springer; Berlin: 1999
- 1b Coppola GM, Schuster FH. α-Hydroxy Acids in Enantioselective Syntheses. VCH; Weinheim: 1997
- 1c Juan Y.-P, Tsai T.-H. J. Chromatogr. A 2005; 1088: 146
- 1d Hill JC, White RH, Barratt MD, Mignini E. J. Appl. Cosmetol. 1988; 6: 53
- 1e Funke AB. H, Ernsting MJ. E, Rekker RF, Nauta WT. Arzneim.-Forsch. 1953; 3: 503
- 1f Daußmann T, Hennemann HG, Rosen TC, Dünkelmann P. Chem. Ing. Tech. 2006; 78: 249
- 2a Zhu D, Yang Y, Hua L. J. Org. Chem. 2006; 71: 4202
- 2b Kratzer R, Nidetzky B. Chem. Commun. 2007; 1047
- 2c Kanomata N, Nakata T. J. Am. Chem. Soc. 2000; 122: 4563
- 2d He C, Chang D, Zhang J. Tetrahedron: Asymmetry 2008; 19: 1347
- 2e Applegate GA, Cheloha RW, Nelson DL, Berkowitz DB. Chem. Commun. 2011; 47: 2420
- 3a Zhu L, Meng Q, Fan W, Xie X, Zhang Z. J. Org. Chem. 2010; 75: 6027
- 3b Yan P.-C, Xie J.-H, Zhang X.-D, Chen K, Li Y.-Q, Zhou Q.-L, Che D.-Q. Chem. Commun. 2014; 50: 15987
- 3c Sun X, Zhou L, Li W, Zhang X. J. Org. Chem. 2008; 73: 1143
- 3d Ramachandran PV, Pitre S, Brown HC. J. Org. Chem. 2002; 67: 5315
- 3e Meng Q, Sun Y, Ratovelomanana-Vidal V, Genêt JP, Zhang Z. J. Org. Chem. 2008; 73: 3842
- 3f Enders D, Stöckel BA, Rembiak A. Chem. Commun. 2014; 50: 4489
- 3g Wu W, Zou S, Lin L, Ji J, Zhang Y, Ma B, Liu X, Feng X. Chem. Commun. 2017; 53: 3232
- 3h Gu G, Yang T, Lu J, Wen J, Dang L, Zhang X. Org. Chem. Front. 2018; 5: 1209
- 4a Ishihara K, Yano T, Fushimi M. J. Fluorine Chem. 2008; 129: 994
- 4b Russell AE, Miller SP, Morken JP. J. Org. Chem. 2000; 65: 8381
- 4c Schmitt E, Schiffers I, Bolm C. Tetrahedron Lett. 2009; 50: 3185
- 4d Wang P, Tao W.-J, Sun X.-L, Liao S, Tang Y. J. Am. Chem. Soc. 2013; 135: 16849
- 4e Wu W, Liu X, Zhang Y, Ji J, Huang T, Lin L, Feng X. Chem. Commun. 2015; 51: 11646
- 5a Zhang Y, Liu X, Zhou L, Wu W, Huang T, Liao Y, Lin L, Feng X. Chem. Eur. J. 2014; 20: 15884
- 5b Tang L, Deng L. J. Am. Chem. Soc. 2002; 124: 2870
- 5c Sakakura A, Umemura S, Ishihara K. Synlett 2009; 1647
- 5d Ebbers EJ, Ariaans GJ. A, Bruggink A, Zwanenburg B. Tetrahedron: Asymmetry 1999; 10: 3701
- 5e Alamsetti SK, Sekar G. Chem. Commun. 2010; 46: 7235
- 6a Bigi F, Bocelli G, Maggi R, Sartori G. J. Org. Chem. 1999; 64: 5004
- 6b Gathergood N, Zhuang W, Jørgensen KA. J. Am. Chem. Soc. 2000; 122: 12517
- 6c Majer J, Kwiatkowski P, Jurczak J. Org. Lett. 2008; 10: 2955
- 6d Majer J, Kwiatkowski P, Jurczak J. Org. Lett. 2009; 11: 4636
- 6e Malhotra SV, Xiao Y. Aust. J. Chem. 2006; 59: 468
- 6f Vila C, Quintero L, Blay G, Muñoz MC, Pedro JR. Org. Lett. 2016; 18: 5652
- 6g Yuan Y, Wang X, Li X, Ding K. J. Org. Chem. 2004; 69: 146
- 6h Zhang W, Wang PG. J. Org. Chem. 2000; 65: 4732
- 7 Aikawa K, Hioki Y, Mikami K. Chem. Asian J. 2010; 5: 2346
- 8a Marques CS, Burke AJ. Tetrahedron: Asymmetry 2013; 24: 628
- 8b Marques CS, Dindaroğlu M, Schmalz H.-G, Burke AJ. RSC Adv. 2014; 4: 6035
- 8c Yamamoto Y, Shirai T, Miyaura N. Chem. Commun. 2012; 48: 2803
- 9a Feng X, Du H. Asian J. Org. Chem. 2012; 1: 204
- 9b Li Y, Xu M.-H. Chem. Commun. 2014; 50: 3771
- 9c Dong H.-Q, Xu M.-H, Feng C.-G, Sun X.-W, Lin G.-Q. Org. Chem. Front. 2015; 2: 73
- 10a Zhu T.-S, Jin S.-S, Xu M.-H. Angew. Chem. Int. Ed. 2012; 51: 780
- 10b Wang H, Zhu T.-S, Xu M.-H. Org. Biomol. Chem. 2012; 10: 9158
- 10c Zhu T.-S, Chen J.-P, Xu M.-H. Chem. Eur. J. 2013; 19: 865
- 10d Zhu D.-X, Chen W.-W, Xu M.-H. Tetrahedron 2016; 72: 2637
- 10e Zhang Z.-F, Zhu D.-X, Chen W.-W, Xu B, Xu M.-H. Org. Lett. 2017; 19: 2726
- 11a Wang H, Jiang T, Xu M.-H. J. Am. Chem. Soc. 2013; 135: 971
- 11b Wang H, Li Y, Xu M.-H. Org. Lett. 2014; 16: 3962
- 11c Jiang T, Wang Z, Xu M.-H. Org. Lett. 2015; 17: 528
- 11d Liu M.-Q, Jiang T, Xu M.-H. Org. Chem. Front. 2016; 3: 944
- 11e Zhang X, Xu B, Xu M.-H. Org. Chem. Front. 2017; 4: 2159
- 11f Jiang T, Chen W.-W, Xu M.-H. Org. Lett. 2017; 19: 2138
- 12 Liu G, Cogan DA, Ellman JA. J. Am. Chem. Soc. 1997; 119: 9913
- 13 In Rh-catalyzed asymmetric 1,4-additions, the carbon chirality has no effect on the enantioselectivity control, see: Feng X, Wang Y, Wei B, Yang J, Du H. Org. Lett. 2011; 13: 3300
- 14 CCDC 1919774 contains the supplementary crystallographic data for compound L12. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/getstructures
- 15 Blay G, Fernández I, Marco-Aleixandre A, Pedro JR. Org. Lett. 2006; 8: 1287
- 16 Castaldi G, Barreca G, Bologna A. WO 03093276, 2003
- 17 Isopropyl Aryl(hydroxy)acetates 3a–q; General ProcedureUnder an Ar atmosphere, a solution of the appropriate glyoxylate 1 (0.2 mmol), [Rh(COE)2Cl]2 (1.5 mol%), L12 (3.3 mol%), and arylboronic acid (0.4 mmol) in 1,4-dioxane (2 mL) was stirred at r.t. for 30 min. 0.1 M aq KOH (0.1 mL, 0.01 mmol) was then added and the resulting mixture was stirred 40 °C for 5 h until the starting materials disappeared (TLC). The solvent was evaporated under vacuum and the residue was purified by column chromatography (silica gel).
- 18 Isopropyl (2S)-(3,4-Dimethoxyphenyl)(hydroxy)acetate (3o)White solid; yield: 38.1 mg (75%, 72% ee). 1H NMR (400 MHz, CDCl3): δ = 7.01–6.90 (m, 2 H), 6.84 (d, J = 8.2 Hz, 1 H), 5.07 (m, 2 H), 3.88 (d, J = 1.2 Hz, 6 H), 3.54 (s, 1 H), 1.28 (d, J = 6.2 Hz, 3 H), 1.13 (d, J = 6.3 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 173.4, 149.1, 149.0, 131.2, 119.1, 111.0, 109.4, 72.7, 70.1, 55.9, 55.9, 21.8, 21.5.Isopropyl (2S)-(3,5-Dimethoxyphenyl)(hydroxy)acetate (3q)White solid; yield: 50.3 mg (99%, 75% ee). 1H NMR (400 MHz, CDCl3): δ = 7.01–6.90 (m, 2 H), 6.84 (d, J = 8.2 Hz, 1 H), 5.07 (m, 2 H), 3.88 (s, 6 H), 3.54 (s, 1 H), 1.28 (d, J = 6.2 Hz, 3 H), 1.13 (d, J = 6.3 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 173.1, 160.9, 140.9, 104.4, 100.6, 73.0, 70.3, 55.4, 21.8, 21.5.
-
References and Notes
- 1a Comprehensive Asymmetric Catalysis . Jacobsen EN, Pfaltz A, Yamamoto H. Springer; Berlin: 1999
- 1b Coppola GM, Schuster FH. α-Hydroxy Acids in Enantioselective Syntheses. VCH; Weinheim: 1997
- 1c Juan Y.-P, Tsai T.-H. J. Chromatogr. A 2005; 1088: 146
- 1d Hill JC, White RH, Barratt MD, Mignini E. J. Appl. Cosmetol. 1988; 6: 53
- 1e Funke AB. H, Ernsting MJ. E, Rekker RF, Nauta WT. Arzneim.-Forsch. 1953; 3: 503
- 1f Daußmann T, Hennemann HG, Rosen TC, Dünkelmann P. Chem. Ing. Tech. 2006; 78: 249
- 2a Zhu D, Yang Y, Hua L. J. Org. Chem. 2006; 71: 4202
- 2b Kratzer R, Nidetzky B. Chem. Commun. 2007; 1047
- 2c Kanomata N, Nakata T. J. Am. Chem. Soc. 2000; 122: 4563
- 2d He C, Chang D, Zhang J. Tetrahedron: Asymmetry 2008; 19: 1347
- 2e Applegate GA, Cheloha RW, Nelson DL, Berkowitz DB. Chem. Commun. 2011; 47: 2420
- 3a Zhu L, Meng Q, Fan W, Xie X, Zhang Z. J. Org. Chem. 2010; 75: 6027
- 3b Yan P.-C, Xie J.-H, Zhang X.-D, Chen K, Li Y.-Q, Zhou Q.-L, Che D.-Q. Chem. Commun. 2014; 50: 15987
- 3c Sun X, Zhou L, Li W, Zhang X. J. Org. Chem. 2008; 73: 1143
- 3d Ramachandran PV, Pitre S, Brown HC. J. Org. Chem. 2002; 67: 5315
- 3e Meng Q, Sun Y, Ratovelomanana-Vidal V, Genêt JP, Zhang Z. J. Org. Chem. 2008; 73: 3842
- 3f Enders D, Stöckel BA, Rembiak A. Chem. Commun. 2014; 50: 4489
- 3g Wu W, Zou S, Lin L, Ji J, Zhang Y, Ma B, Liu X, Feng X. Chem. Commun. 2017; 53: 3232
- 3h Gu G, Yang T, Lu J, Wen J, Dang L, Zhang X. Org. Chem. Front. 2018; 5: 1209
- 4a Ishihara K, Yano T, Fushimi M. J. Fluorine Chem. 2008; 129: 994
- 4b Russell AE, Miller SP, Morken JP. J. Org. Chem. 2000; 65: 8381
- 4c Schmitt E, Schiffers I, Bolm C. Tetrahedron Lett. 2009; 50: 3185
- 4d Wang P, Tao W.-J, Sun X.-L, Liao S, Tang Y. J. Am. Chem. Soc. 2013; 135: 16849
- 4e Wu W, Liu X, Zhang Y, Ji J, Huang T, Lin L, Feng X. Chem. Commun. 2015; 51: 11646
- 5a Zhang Y, Liu X, Zhou L, Wu W, Huang T, Liao Y, Lin L, Feng X. Chem. Eur. J. 2014; 20: 15884
- 5b Tang L, Deng L. J. Am. Chem. Soc. 2002; 124: 2870
- 5c Sakakura A, Umemura S, Ishihara K. Synlett 2009; 1647
- 5d Ebbers EJ, Ariaans GJ. A, Bruggink A, Zwanenburg B. Tetrahedron: Asymmetry 1999; 10: 3701
- 5e Alamsetti SK, Sekar G. Chem. Commun. 2010; 46: 7235
- 6a Bigi F, Bocelli G, Maggi R, Sartori G. J. Org. Chem. 1999; 64: 5004
- 6b Gathergood N, Zhuang W, Jørgensen KA. J. Am. Chem. Soc. 2000; 122: 12517
- 6c Majer J, Kwiatkowski P, Jurczak J. Org. Lett. 2008; 10: 2955
- 6d Majer J, Kwiatkowski P, Jurczak J. Org. Lett. 2009; 11: 4636
- 6e Malhotra SV, Xiao Y. Aust. J. Chem. 2006; 59: 468
- 6f Vila C, Quintero L, Blay G, Muñoz MC, Pedro JR. Org. Lett. 2016; 18: 5652
- 6g Yuan Y, Wang X, Li X, Ding K. J. Org. Chem. 2004; 69: 146
- 6h Zhang W, Wang PG. J. Org. Chem. 2000; 65: 4732
- 7 Aikawa K, Hioki Y, Mikami K. Chem. Asian J. 2010; 5: 2346
- 8a Marques CS, Burke AJ. Tetrahedron: Asymmetry 2013; 24: 628
- 8b Marques CS, Dindaroğlu M, Schmalz H.-G, Burke AJ. RSC Adv. 2014; 4: 6035
- 8c Yamamoto Y, Shirai T, Miyaura N. Chem. Commun. 2012; 48: 2803
- 9a Feng X, Du H. Asian J. Org. Chem. 2012; 1: 204
- 9b Li Y, Xu M.-H. Chem. Commun. 2014; 50: 3771
- 9c Dong H.-Q, Xu M.-H, Feng C.-G, Sun X.-W, Lin G.-Q. Org. Chem. Front. 2015; 2: 73
- 10a Zhu T.-S, Jin S.-S, Xu M.-H. Angew. Chem. Int. Ed. 2012; 51: 780
- 10b Wang H, Zhu T.-S, Xu M.-H. Org. Biomol. Chem. 2012; 10: 9158
- 10c Zhu T.-S, Chen J.-P, Xu M.-H. Chem. Eur. J. 2013; 19: 865
- 10d Zhu D.-X, Chen W.-W, Xu M.-H. Tetrahedron 2016; 72: 2637
- 10e Zhang Z.-F, Zhu D.-X, Chen W.-W, Xu B, Xu M.-H. Org. Lett. 2017; 19: 2726
- 11a Wang H, Jiang T, Xu M.-H. J. Am. Chem. Soc. 2013; 135: 971
- 11b Wang H, Li Y, Xu M.-H. Org. Lett. 2014; 16: 3962
- 11c Jiang T, Wang Z, Xu M.-H. Org. Lett. 2015; 17: 528
- 11d Liu M.-Q, Jiang T, Xu M.-H. Org. Chem. Front. 2016; 3: 944
- 11e Zhang X, Xu B, Xu M.-H. Org. Chem. Front. 2017; 4: 2159
- 11f Jiang T, Chen W.-W, Xu M.-H. Org. Lett. 2017; 19: 2138
- 12 Liu G, Cogan DA, Ellman JA. J. Am. Chem. Soc. 1997; 119: 9913
- 13 In Rh-catalyzed asymmetric 1,4-additions, the carbon chirality has no effect on the enantioselectivity control, see: Feng X, Wang Y, Wei B, Yang J, Du H. Org. Lett. 2011; 13: 3300
- 14 CCDC 1919774 contains the supplementary crystallographic data for compound L12. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/getstructures
- 15 Blay G, Fernández I, Marco-Aleixandre A, Pedro JR. Org. Lett. 2006; 8: 1287
- 16 Castaldi G, Barreca G, Bologna A. WO 03093276, 2003
- 17 Isopropyl Aryl(hydroxy)acetates 3a–q; General ProcedureUnder an Ar atmosphere, a solution of the appropriate glyoxylate 1 (0.2 mmol), [Rh(COE)2Cl]2 (1.5 mol%), L12 (3.3 mol%), and arylboronic acid (0.4 mmol) in 1,4-dioxane (2 mL) was stirred at r.t. for 30 min. 0.1 M aq KOH (0.1 mL, 0.01 mmol) was then added and the resulting mixture was stirred 40 °C for 5 h until the starting materials disappeared (TLC). The solvent was evaporated under vacuum and the residue was purified by column chromatography (silica gel).
- 18 Isopropyl (2S)-(3,4-Dimethoxyphenyl)(hydroxy)acetate (3o)White solid; yield: 38.1 mg (75%, 72% ee). 1H NMR (400 MHz, CDCl3): δ = 7.01–6.90 (m, 2 H), 6.84 (d, J = 8.2 Hz, 1 H), 5.07 (m, 2 H), 3.88 (d, J = 1.2 Hz, 6 H), 3.54 (s, 1 H), 1.28 (d, J = 6.2 Hz, 3 H), 1.13 (d, J = 6.3 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 173.4, 149.1, 149.0, 131.2, 119.1, 111.0, 109.4, 72.7, 70.1, 55.9, 55.9, 21.8, 21.5.Isopropyl (2S)-(3,5-Dimethoxyphenyl)(hydroxy)acetate (3q)White solid; yield: 50.3 mg (99%, 75% ee). 1H NMR (400 MHz, CDCl3): δ = 7.01–6.90 (m, 2 H), 6.84 (d, J = 8.2 Hz, 1 H), 5.07 (m, 2 H), 3.88 (s, 6 H), 3.54 (s, 1 H), 1.28 (d, J = 6.2 Hz, 3 H), 1.13 (d, J = 6.3 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 173.1, 160.9, 140.9, 104.4, 100.6, 73.0, 70.3, 55.4, 21.8, 21.5.









